Fenwick represented Oshi Health, the virtual specialty care company transforming gastrointestinal (GI) health outcomes and economics, in its $30 million Series B financing. The round was led by Koch Disruptive Technologies with participation from Bessemer Venture Partners, Flare Capital Partners, Frist Cressey Ventures, CVS Health Ventures and Takeda Digital Ventures.
Oshi Health will use the new capital to scale access to its virtual multidisciplinary digestive care. More information can be obtained from the company’s announcement.
The transaction was led by corporate partner Evan Bienstock and associates Stephanie Hong and Michelle Le.